Works matching IS 17597706 AND DT 2021 AND VI 12 AND IP 16
Results: 10
Durable response to EGFR tyrosine kinase inhibitors in a patient with non–small cell lung cancer harboring an EGFR kinase domain duplication.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2283, doi. 10.1111/1759-7714.14081
- By:
- Publication type:
- Article
Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2265, doi. 10.1111/1759-7714.14070
- By:
- Publication type:
- Article
Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2279, doi. 10.1111/1759-7714.14068
- By:
- Publication type:
- Article
Histone methyltransferase SETD1A participates in lung cancer progression.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2247, doi. 10.1111/1759-7714.14065
- By:
- Publication type:
- Article
Multiple calcifying fibrous tumor of the pleura: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2271, doi. 10.1111/1759-7714.14064
- By:
- Publication type:
- Article
Feasibility of an outpatient‐based pulmonary rehabilitation program for lung cancer patients during radiation therapy.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2241, doi. 10.1111/1759-7714.14061
- By:
- Publication type:
- Article
Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR‐578.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2258, doi. 10.1111/1759-7714.14059
- By:
- Publication type:
- Article
Concurrent chemotherapy and first‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first‐line treatment in advanced lung adenocarcinoma harboring an EGFR mutation
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2233, doi. 10.1111/1759-7714.14057
- By:
- Publication type:
- Article
Response to lorlatinib on a patient with ALK‐rearranged non‐small cell lung cancer harboring 1151Tins mutation with uterine metastasis.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2275, doi. 10.1111/1759-7714.14056
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 16, p. 2231, doi. 10.1111/1759-7714.13805
- Publication type:
- Article